No One Missed: Empowering Lung Cancer Patients with Biomarker Insights
Science With a Twist Podcast: Season 2 Episode 8 Biomarker testing for targeted therapies is a game changer for lung cancer, and it ensures that patients get the proper treatment at the right time. But how do we make it accessible to all patients, regardless of race or ethnicity? In this episode of the Science with a Twist podcast, our host Jeff Smith welcomes Dr. Upal Basu Roy, the executive director of Research at LUNGevity. They talk about the importance of diversity in the oncology workforce, why it's essential to be more inclusive, and the critical role of biomarkers and targeted therapies for lung cancer patients.
Suggested videos

Thermo Fisher Scientific
Thermo Fisher Scientific · 1:01

Lung Cancer Biomarker Testing
American Lung Association · 48:19

Thermo Fisher Scientific - Fisher Clinical Services, Allentown
Fisher Clinical Services · 2:58

Lung Precision Oncology
Veterans Health Administration · 3:48

Thermo Fisher Scientific Microarray Technology
Thermo Fisher Scientific · 2:37

What if I Don't Have a Biomarker?
Lung Cancer Foundation of America · 3:26

Thermo Fisher Scientific – Clinical Research
Thermo Fisher Scientific · 1:46

Achieving Better Lung Cancer Outcomes Through Early Detection and Treatment
Icahn School of Medicine · 56:05

Manufacturing Medicine at Thermo Fisher Scientific – St. Louis
Thermo Fisher Scientific · 3:29

Advantages of Next Generation Sequencing in NSCLC - 2022 Program: Targeted Therapies Forum - English
Global Resource for Advancing Cancer Education · 3:20

A Look Inside Thermo Fisher Scientific’s New Clinical Research Laboratory in Middleton, Wisconsin
Thermo Fisher Scientific · 2:22

Lung Cancer Webinar
RWJBarnabas Health · 28:20